Just to put a finer point on this comparison with

Just to put a finer point on this comparison with Anacor from page 5 in the 10K...

Quote:

---

We are a clinical stage company. We have no product sales to date and we will not receive any product revenue until we receive approval from the FDA or
equivalent foreign regulatory agencies to begin marketing a pharmaceutical product. Developing pharmaceutical products, however, is a lengthy and very
expensive process. Assuming we do not encounter any unforeseen safety or efficacy issues during the course of developing our product candidates, we do
not expect to complete the development of a product candidate for several years, if ever.

---

In the company's own words we are "several years" (minus ~6 months) from the point at which Anacor was purchased for it's nearly NDA-granted Crisaborole.

Again, Anacor took 18% of Pfizer's estimated lifetime value at that point. What would we take four years prior to that point?

In light of what we received today, I think a $7-21/share buyout would be a dream come true if announced tomorrow. I don't even want to address the "if ever" cherry on the top of that shite sundae.

Where are the other $10B+ guys today? Kelt? Scgmck? A lot of guys in their 60s and beyond here don't want to wait several more years. Only so many good years left. Buyout is best for everyone.

I rest my case.